A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2023

Primary Completion Date

March 14, 2023

Study Completion Date

March 14, 2023

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Fexofenadine

Fexofenadine oral tablet

DRUG

Placebo

Fexofenadine matching placebo oral tablet

Trial Locations (1)

Investigational Site Number : 1240001, Kingston

All Listed Sponsors

lead

Opella Healthcare Group SAS, a Sanofi Company

INDUSTRY